Doctor Masaharu Akao

Doctor Masaharu Akao

Kyoto Medical Centre, Kyoto (Japan)

Member of:

Dr Akao is the Director and Chief at Department of Cardiology, National Hospital Organization Kyoto Medical Center (Kyoto Japan). He is also a Clinical Professor at Kyoto University Graduate School of Medicine and a board member of the Japanese Society of Internal Medicine, the Japanese Circulation Society, and Japanese Heart Rhythm Society. His research interests include epidemiology and medical management of atrial fibrillation (AF), and pharmacology of oral anticoagulant drugs. He is principal investigator of the Fushimi AF registry, a community-based prospective observational survey of Japanese patients with AF, and a co-investigator of ELDERCARE-AF trial, AFIRE trial and ANAFIE registry.

Presentations Articles

Q&A and discussion

Event: ESC Congress 2024

Topic: Oral Anticoagulation

Session: Personalised anticoagulation therapy in eligible patients with atrial fibrillation

Access

Challenging clinical scenarios for therapeutic anticoagulation: a practical approach

Event: ESC Congress 2024

Topic: Oral Anticoagulation

Session: Personalised anticoagulation therapy in eligible patients with atrial fibrillation

Access

Association of beta blocker use with new-onset heart failure and mortality in atrial fibrillation without pre-existing heart failure: the Fushimi AF registry

Event: ESC Congress 2022

Topic: Prevention

Session: Chronic heart failure and atrial fibrillation

Access

Association of cardiothoracic ratio with heart failure hospitalization in patients with atrial fibrillation: the Fushimi AF Registry

Event: ESC Congress 2022

Topic: Imaging

Session: Chronic heart failure and atrial fibrillation

Access

Usefulness of echocardiographic parameters in predicting the incidence of ischemic stroke in japanese patients with non-valvular atrial fibrillation.

Event: ESC Congress 2022

Topic: Stroke in Atrial Fibrillation

Session: How to prevent best prevent stroke in atrial fibrillation patients

Access

Balancing stroke and bleeding risks in Asian patients with atrial fibrillation.

Event: ESC Congress 2020

Topic: Stroke

Session: Racial and Cultural Differences in anti-Thrombotic Therapy between Europe and Asia

Access

Impact of creatinine clearance on clinical outcomes in elderly atrial fibrillation patients receiving apixaban: J-ELD AF Registry sub-analysis

Event: ESC Congress 2020

Topic: Oral Anticoagulation

Session: Atrial Fibrillation ePosters

Access

Left atrial enlargement as an independent risk factor for ischemic stroke in Japanese atrial fibrillation patients: pooled analysis of five major Japanese atrial fibrillation registries

Event: ESC Congress 2019

Topic: Stroke Prevention

Session: Epidemiology of atrial fibrillation

Access

Case 2: an atrial fibrillation patient with high CHA2DS2-VASc Score, a gastrointestinal bleed and renal impairment

Event: ESC Congress 2018

Topic: Atrial Fibrillation (AF)

Session: Atrial fibrillation: from Guidelines to clinical practice

Access

Temporal change of anticoagulation therapy and its outcomes of Japanese atrial fibrillation patients in the real-world clinical practice: the Fushimi AF Registry.

Event: ESC Congress 2016

Topic: Atrial fibrillation (AF)

Session: Antithrombotic therapy in atrial fibrillation 2

Access

ESC 365 is supported by

Explore sponsored resources

Doctor Masaharu Akao

Biography

Contributor content

Q&A and discussion

Challenging clinical scenarios for therapeutic anticoagulation: a practical approach

Association of beta blocker use with new-onset heart failure and mortality in atrial fibrillation without pre-existing heart failure: the Fushimi AF registry

Association of cardiothoracic ratio with heart failure hospitalization in patients with atrial fibrillation: the Fushimi AF Registry

Usefulness of echocardiographic parameters in predicting the incidence of ischemic stroke in japanese patients with non-valvular atrial fibrillation.

Balancing stroke and bleeding risks in Asian patients with atrial fibrillation.

Impact of creatinine clearance on clinical outcomes in elderly atrial fibrillation patients receiving apixaban: J-ELD AF Registry sub-analysis

Left atrial enlargement as an independent risk factor for ischemic stroke in Japanese atrial fibrillation patients: pooled analysis of five major Japanese atrial fibrillation registries

Case 2: an atrial fibrillation patient with high CHA2DS2-VASc Score, a gastrointestinal bleed and renal impairment

Temporal change of anticoagulation therapy and its outcomes of Japanese atrial fibrillation patients in the real-world clinical practice: the Fushimi AF Registry.

ESC 365 is supported by

Doctor Masaharu Akao Follow

Biography

Contributor content

Q&A and discussion

Challenging clinical scenarios for therapeutic anticoagulation: a practical approach

Association of beta blocker use with new-onset heart failure and mortality in atrial fibrillation without pre-existing heart failure: the Fushimi AF registry

Association of cardiothoracic ratio with heart failure hospitalization in patients with atrial fibrillation: the Fushimi AF Registry

Usefulness of echocardiographic parameters in predicting the incidence of ischemic stroke in japanese patients with non-valvular atrial fibrillation.

Balancing stroke and bleeding risks in Asian patients with atrial fibrillation.

Impact of creatinine clearance on clinical outcomes in elderly atrial fibrillation patients receiving apixaban: J-ELD AF Registry sub-analysis

Left atrial enlargement as an independent risk factor for ischemic stroke in Japanese atrial fibrillation patients: pooled analysis of five major Japanese atrial fibrillation registries

Case 2: an atrial fibrillation patient with high CHA2DS2-VASc Score, a gastrointestinal bleed and renal impairment

Temporal change of anticoagulation therapy and its outcomes of Japanese atrial fibrillation patients in the real-world clinical practice: the Fushimi AF Registry.

ESC 365 is supported by

Doctor Masaharu Akao